{"disease":{"id":"untreated-metastatic-colorectal-cancer","name":"untreated metastatic colorectal cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07221357","title":"A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":990,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT02305758","title":"Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"AbbVie","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}